ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Clinical trials for ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA explained in plain language.
Never miss a new study
Get alerted when new ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA trials appear
Sign up with your email to follow new studies for ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-world study examines caplacizumab for aTTP: better treatment on the horizon?
Disease control OngoingThis study looks back at how doctors in Germany prescribed caplacizumab (Cablivi) for acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood clotting disorder. Researchers will analyze data from 350 patients to see how well the drug works outside of clinical trials and…
Matched conditions: ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Sponsor: University of Cologne • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New rapid test could speed up diagnosis of deadly blood clotting disorder
Diagnosis OngoingThis study is testing a new, faster blood test for diagnosing acquired thrombotic thrombocytopenic purpura (aTTP), a rare but life-threatening blood clotting disorder. The new test, called HemosIL AcuStar, will be compared to two existing tests in 500 patients from Spain and Port…
Matched conditions: ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Sponsor: Fundación Española de Hematología y Hemoterapía • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC